LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023.

    Ajiboye, Aderonke S / O'Connor, Stephanie / Smith, Jonathan P / Ahmedov, Sevim / Coggin, William L / Charles, Macarthur / Ghosh, Smita / Pierre, Paul / Shah, Neha / Teran, Richard A / Moonan, Patrick K / Date, Anand

    MMWR. Morbidity and mortality weekly report

    2024  Volume 73, Issue 11, Page(s) 233–238

    Abstract: Tuberculosis (TB) is the leading cause of death among persons with HIV. In 2022, an estimated 167,000 TB-related deaths occurred globally among persons with HIV. TB preventive treatment (TPT) helps prevent TB disease and is recommended for persons at ... ...

    Abstract Tuberculosis (TB) is the leading cause of death among persons with HIV. In 2022, an estimated 167,000 TB-related deaths occurred globally among persons with HIV. TB preventive treatment (TPT) helps prevent TB disease and is recommended for persons at high risk for developing TB, including those with HIV. TPT, when taken with antiretroviral treatment (ART), can reduce TB-attributable deaths among persons with HIV. In 2018, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program committed to offer one course of TPT to all eligible clients receiving ART. This analysis describes trends in TPT initiation and completion among PEPFAR-supported programs in 36 countries in Africa, Central and South America, and Asia during fiscal years (FYs) 2017-2023. Overall, TPT initiation rates peaked in FY19, a possible sign of programmatic saturation. TPT initiation among clients who had been on ART <6 months reached 59%, and overall completion rates up to 87% were reported. Approximately 13 million persons with HIV have completed TPT since FY17, but widespread adoption of shorter regimens, patient-centered approaches, and electronic medical record systems might be needed to ensure full TPT coverage. Through PEPFAR's partnership with national HIV programs, TPT has become the standard of care for persons with HIV.
    MeSH term(s) Humans ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; HIV Infections/drug therapy ; Acquired Immunodeficiency Syndrome/prevention & control ; International Cooperation ; Tuberculosis/epidemiology ; Tuberculosis/prevention & control ; Africa ; Anti-Retroviral Agents/therapeutic use
    Chemical Substances Anti-Retroviral Agents
    Language English
    Publishing date 2024-03-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 412775-4
    ISSN 1545-861X ; 0149-2195
    ISSN (online) 1545-861X
    ISSN 0149-2195
    DOI 10.15585/mmwr.mm7311a1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Rolling Out Xpert

    Pathmanathan, Ishani / Date, Anand / Coggin, William L / Nkengasong, John / Piatek, Amy S / Alexander, Heather

    African journal of laboratory medicine

    2017  Volume 6, Issue 2

    Abstract: Background: To eliminate preventable deaths, disease and suffering due to tuberculosis (TB), improved diagnostic capacity is critical. The Cepheid Xpert: Opportunities for system strengthening: In this commentary we discuss needs and opportunities ... ...

    Abstract Background: To eliminate preventable deaths, disease and suffering due to tuberculosis (TB), improved diagnostic capacity is critical. The Cepheid Xpert
    Opportunities for system strengthening: In this commentary we discuss needs and opportunities for systems strengthening to support widespread scale-up of Xpert
    Conclusion: Xpert
    Language English
    Publishing date 2017-07-18
    Publishing country South Africa
    Document type Journal Article
    ZDB-ID 2708535-1
    ISSN 2225-2010 ; 2225-2002
    ISSN (online) 2225-2010
    ISSN 2225-2002
    DOI 10.4102/ajlm.v6i2.460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.

    Coggin, William L / Ryan, Caroline A / Holmes, Charles B

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2010  Volume 50 Suppl 3, Page(s) S255–9

    Abstract: The intersection of tuberculosis (TB) and human immunodeficiency virus (HIV) infection has eroded gains made in TB control, because previously well-functioning national TB programs have been overwhelmed by the dual challenges posed by TB and HIV ... ...

    Abstract The intersection of tuberculosis (TB) and human immunodeficiency virus (HIV) infection has eroded gains made in TB control, because previously well-functioning national TB programs have been overwhelmed by the dual challenges posed by TB and HIV coinfection. The US President's Emergency Plan for AIDS Relief (PEPFAR), through its direct support of >2.4 million persons receiving HIV treatment and, in 2009, support of >308,000 HIV-infected persons receiving TB treatment, works closely with national governments and other partners to strengthen the response to TB and HIV coinfection. PEPFAR-supported activities fall within the World Health Organization's 2004 framework for collaborative TB and HIV activities, including critical interventions to (1) develop organizational methods of collaboration across the 2 programs, (2) reduce the burden of HIV infection among patients with TB, and (3) reduce the burden of TB among persons with HIV infection or AIDS. To date, PEPFAR and partners have made important gains in coverage and scope of HIV testing, referral, and antiretroviral therapy for patients with TB. TB screening of HIV-infected patients is also beginning to increase, although greater progress needs to be made in increasing access to isoniazid preventive therapy and strengthening TB infection control. Continued strategic integration of TB and HIV interventions into PEPFAR-supported programs is essential to easing the patient burden of dual infection, improving patient outcomes, and, ultimately, decreasing rates of TB in areas with a high prevalence of TB.
    MeSH term(s) AIDS-Related Opportunistic Infections/drug therapy ; AIDS-Related Opportunistic Infections/economics ; AIDS-Related Opportunistic Infections/epidemiology ; AIDS-Related Opportunistic Infections/prevention & control ; Communicable Disease Control/economics ; Financial Management/organization & administration ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/economics ; HIV Infections/epidemiology ; HIV Infections/prevention & control ; Humans ; Tuberculosis/drug therapy ; Tuberculosis/economics ; Tuberculosis/epidemiology ; Tuberculosis/prevention & control ; United States/epidemiology
    Language English
    Publishing date 2010-05-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1086/651499
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: GeneXpert for TB diagnosis: planned and purposeful implementation.

    Piatek, Amy S / Van Cleeff, Maarten / Alexander, Heather / Coggin, William L / Rehr, Manuela / Van Kampen, Sanne / Shinnick, Thomas M / Mukadi, YaDiul

    Global health, science and practice

    2013  Volume 1, Issue 1, Page(s) 18–23

    Abstract: Xpert MTB/RIF is a major advance for TB diagnostics, especially for multidrug-resistant (MDR) TB and HIV-associated TB. But implementation concerns including cost, technical support requirements, and challenging demands of providing second-line TB drugs ... ...

    Abstract Xpert MTB/RIF is a major advance for TB diagnostics, especially for multidrug-resistant (MDR) TB and HIV-associated TB. But implementation concerns including cost, technical support requirements, and challenging demands of providing second-line TB drugs for diagnosed MDR-TB cases call for gradual, careful introduction based on country circumstances.
    Language English
    Publishing date 2013-03-21
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2710875-2
    ISSN 2169-575X
    ISSN 2169-575X
    DOI 10.9745/GHSP-D-12-00004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: PEPFAR support for the scaling up of collaborative TB/HIV activities.

    Howard, Andrea A / Gasana, Michel / Getahun, Haileyesus / Harries, Anthony / Lawn, Stephen D / Miller, Bess / Nelson, Lisa / Sitienei, Joseph / Coggin, William L

    Journal of acquired immune deficiency syndromes (1999)

    2012  Volume 60 Suppl 3, Page(s) S136–44

    Abstract: The US President's Emergency Plan for AIDS Relief (PEPFAR) has supported a comprehensive package of care in which interventions to address HIV-related tuberculosis (TB) have received increased funding and support in recent years. PEPFAR's TB/HIV ... ...

    Abstract The US President's Emergency Plan for AIDS Relief (PEPFAR) has supported a comprehensive package of care in which interventions to address HIV-related tuberculosis (TB) have received increased funding and support in recent years. PEPFAR's TB/HIV programming is based on the World Health Organization's 12-point policy for collaborative TB/HIV activities, which are integrated into PEPFAR annual guidance. PEPFAR implementing partners have provided crucial support to TB/HIV collaboration, and as a result, PEPFAR-supported countries in sub-Saharan Africa have made significant gains in HIV testing and counseling of TB patients and linkages to HIV care and treatment, intensified TB case finding, and TB infection control. PEPFAR's support of TB/HIV integration has also included significant investment in health systems, including improved laboratory services and educating and enlarging the workforce. The scale-up of antiretroviral therapy along with support of programs to increase HIV counseling and testing and improve linkage and retention in HIV care may have considerable impact on TB morbidity and mortality, if used synergistically with isoniazid preventive therapy, intensified case finding, and infection control. Issues to be addressed by future programming include accelerating implementation of isoniazid preventive therapy, increasing access and ensuring appropriate use of new TB diagnostics, supporting early initiation of antiretroviral therapy for HIV-infected TB patients, and strengthening systems to monitor and evaluate program implementation.
    MeSH term(s) AIDS-Related Opportunistic Infections/diagnosis ; AIDS-Related Opportunistic Infections/drug therapy ; Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/diagnosis ; Acquired Immunodeficiency Syndrome/drug therapy ; Africa South of the Sahara/epidemiology ; Communicable Disease Control/methods ; Communicable Disease Control/organization & administration ; Communicable Disease Control/trends ; Developing Countries ; Global Health ; Humans ; International Cooperation ; National Health Programs/organization & administration ; National Health Programs/trends ; Public-Private Sector Partnerships/organization & administration ; Public-Private Sector Partnerships/trends ; Tuberculosis/complications ; Tuberculosis/diagnosis ; Tuberculosis/drug therapy ; United States
    Language English
    Publishing date 2012-07-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 645053-2
    ISSN 1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
    ISSN (online) 1944-7884 ; 1077-9450
    ISSN 0897-5965 ; 0894-9255 ; 1525-4135
    DOI 10.1097/QAI.0b013e31825cfe8e
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book ; Online: PEPFAR support for the scaling up of collaborative TB/HIV activities

    Sitienei, Joseph / Nelson, Lisa / Miller, Bess / Lawn, Stephen D / Harries, Anthony / Howard, Andrea A / Getahun, Haileyesus / Coggin, William L / Gasana, Michel

    2012  

    Abstract: Research Support, U.S. Gov't, P.H.S. ... Research Support, Non-U.S. Gov't ... Review ...

    Abstract Research Support, U.S. Gov't, P.H.S.

    Research Support, Non-U.S. Gov't

    Review

    Journal Article

    The US President's Emergency Plan for AIDS Relief (PEPFAR) has supported a comprehensive package of care in which interventions to address HIV-related tuberculosis (TB) have received increased funding and support in recent years. PEPFAR's TB/HIV programming is based on the World Health Organization's 12-point policy for collaborative TB/HIV activities, which are integrated into PEPFAR annual guidance. PEPFAR implementing partners have provided crucial support to TB/HIV collaboration, and as a result, PEPFAR-supported countries in sub-Saharan Africa have made significant gains in HIV testing and counseling of TB patients and linkages to HIV care and treatment, intensified TB case finding, and TB infection control. PEPFAR's support of TB/HIV integration has also included significant investment in health systems, including improved laboratory services and educating and enlarging the workforce. The scale-up of antiretroviral therapy along with support of programs to increase HIV counseling and testing and improve linkage and retention in HIV care may have considerable impact on TB morbidity and mortality, if used synergistically with isoniazid preventive therapy, intensified case finding, and infection control. Issues to be addressed by future programming include accelerating implementation of isoniazid preventive therapy, increasing access and ensuring appropriate use of new TB diagnostics, supporting early initiation of antiretroviral therapy for HIV-infected TB patients, and strengthening systems to monitor and evaluate program implementation.
    Language English
    Publishing date 2012-08-01
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top